@article{7af71b89671c457f9daf0a38f382a434,
title = "Determinants of epidemic size and the impacts of lulls in seasonal influenza virus circulation",
abstract = "During the COVID-19 pandemic, levels of seasonal influenza virus circulation were unprecedentedly low, leading to concerns that a lack of exposure to influenza viruses, combined with waning antibody titres, could result in larger and/or more severe post-pandemic seasonal influenza epidemics. However, in most countries the first post-pandemic influenza season was not unusually large and/or severe. Here, based on an analysis of historical influenza virus epidemic patterns from 2002 to 2019, we show that historic lulls in influenza virus circulation had relatively minor impacts on subsequent epidemic size and that epidemic size was more substantially impacted by season-specific effects unrelated to the magnitude of circulation in prior seasons. From measurements of antibody levels from serum samples collected each year from 2017 to 2021, we show that the rate of waning of antibody titres against influenza virus during the pandemic was smaller than assumed in predictive models. Taken together, these results partially explain why the re-emergence of seasonal influenza virus epidemics was less dramatic than anticipated and suggest that influenza virus epidemic dynamics are not currently amenable to multi-season prediction.",
author = "{de Jong}, {Simon P J} and {Felix Garza}, {Zandra C} and Gibson, {Joseph C} and {van Leeuwen}, Sarah and {de Vries}, {Robert P} and Geert-Jan Boons and {van Hoesel}, Marliek and {de Haan}, Karen and {van Groeningen}, {Laura E} and Hulme, {Katina D} and {van Willigen}, {Hugo D G} and Elke Wynberg and {de Bree}, {Godelieve J} and Amy Matser and Margreet Bakker and {van der Hoek}, Lia and Maria Prins and Kootstra, {Neeltje A} and Dirk Eggink and Nichols, {Brooke E} and Han, {Alvin X} and {de Jong}, {Menno D} and Russell, {Colin A}",
note = "Funding Information: A.X.H., Z.C.F.G. and C.A.R. were supported by ERC NaviFlu (No. 818353). J.G. and C.A.R. were supported by NIH R01 (5R01AI132362-04). C.A.R. was also supported by an NWO Vici Award (09150182010027). R.P.d.V. was supported by ERC starting grant 802780 and a Beijerinck Premium of the Royal Dutch Academy of Sciences. G.J.B. was supported by the Netherlands Organization for Scientific Research (NWO TOPPUNT 718.015.003) and by an ERC advanced grant (101020769). The RECoVERED cohort is supported by NWO ZonMw (No. 10150062010002) and the Public Health Service of Amsterdam (Research & Development grant number 21–14). The Amsterdam Cohort Studies on HIV infection and AIDS, a collaboration between the Public Health Service Amsterdam, the Amsterdam UMC of the University of Amsterdam, Medical Center Jan van Goyen and the HIV Focus Center of the DC-Clinics, are part of the Netherlands HIV Monitoring Foundation and financially supported by the Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment. We gratefully acknowledge the authors and originating and submitting laboratories (supplementary information) for the reference sequences retrieved from GISAID{\textquoteright}s EpiFlu Database used in this study. The authors thank all ACS and RECoVERED study participants. We are also grateful to Mr. Reinier van der Palen of the department of Chemical Biology and Drug Discovery, Utrecht University for his practical assistance with turkey erythrocyte glycan remodelling. Publisher Copyright: {\textcopyright} 2024, The Author(s).",
year = "2023",
month = dec,
doi = "https://doi.org/10.1038/s41467-023-44668-z",
language = "English",
volume = "15",
pages = "591",
journal = "Nature communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",
number = "1",
}